[ATTEMPT AT TREATMENT OF HODGKIN'S DISEASE AND VARIOUS HEMATOSARCOMAS WITH 1-METHYL-2-P-ALLOPHANOYL-BENZYLHYDRAZINE HYDROBROMIDE].
D000970:Antineoplastic Agents; D006689:Hodgkin Disease; D006801:Humans; D006834:Hydrazines; D007938:Leukemia; D007945:Leukemia, Lymphoid; D007951:Leukemia, Myeloid; D008223:Lymphoma; D008224:Lymphoma, Follicular; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D009101:Multiple Myeloma; D009182:Mycosis Fungoides; D009369:Neoplasms / Q000628:therapy*; D012509:Sarcoma
D000970:Antineoplastic Agents; D006834:Hydrazines; C006730:benzylhydrazine
ANTINEOPLASTIC AGENTS; HODGKIN'S DISEASE; HYDRAZINES; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MONOCYTIC; LEUKEMIA, MYELOCYTIC; LYMPHOMA; LYMPHOMA, GIANT FOLLICULAR; LYMPHOSARCOMA; MULTIPLE MYELOMA; MYCOSIS FUNGOIDES; NEOPLASM THERAPY; SARCOMA, RETICULUM CELL
ESSAI DE TRAITEMENT PAR LE BROMHYDRATE DE 1-M'ETHYL-2-P-ALLOPHANOYL-BENZYL-HYDRAZINE DE LA MALADIE DE HODGKIN ET DE DIVERS H'EMATOSARCOMES.